Teva raises EUR 2B in debt offering

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) raised EUR 2 billion ($2.2 billion) in a senior notes offering to investors outside the U.S. The offering includes two components: EUR 1.3 billion ($1.4 billion) in notes that are due March 2023 and bear 1.25% interest, and EUR 700 million ($755.7 million) in notes that are due March 2027 and bear 1.875% interest. ...